Resveratrol decreases inflammation and oxidative stress in the mdx mouse model of duchenne muscular dystrophy
2012; Wiley; Volume: 26; Issue: S1 Linguagem: Inglês
10.1096/fasebj.26.1_supplement.823.12
ISSN1530-6860
AutoresBradley S. Gordon, Patti Weed, Emily R. Learner, Drew Schoenling, Matthew C. Kostek,
Tópico(s)Exercise and Physiological Responses
ResumoDuchenne Muscular Dystrophy (DMD) is a genetic disease characterized by muscle damage, oxidative stress, chronic inflammation, and fibrosis. Resveratrol (RES) is an antioxidant and anti‐inflammatory. We have shown that RES improves muscle function in the mdx mouse model of DMD, and others have shown resveratrol decreases fibrosis and oxidative stress in older mdx mice. However, its effect on pathology in young mdx mice is unknown. The purpose of this study was to investigate the effect of resveratrol on muscle pathology in young mdx mice. RES (100 mg/kg) or vehicle was administered to 4–5 week old mdx mice everyday for 10 days or every other day for 8 weeks. Muscle fiber integrity, inflammation, and oxidative stress were assessed by H&E staining and 4‐HNE content. Total inflammation was reduced 21 ± 6% (p < 0.05) after 10 days of treatment with no change in oxidative stress. After 8 weeks of RES treatment, centrally located nuclei were reduced 12 ± 4% (p < 0.05), oxidative stress measured through 4‐HNE content decreased 2 ± 0.13 fold (p < 0.05), and total inflammation and fibrosis did not change. We conclude that RES enhances muscle membrane integrity by reducing inflammation during the peak pathological period and long term oxidative stress. Therefore, resveratrol could be a treatment for boys with DMD. This project was funded by The Center for Alternative Medicine at The University of South Carolina School of Medicine. Grant Funding Source : Center of Alternative Medicine University of South Carolina School of Medicine
Referência(s)